Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07217730

Healthcare Integrity & Anti-Fraud Enforcement

The PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed to restore healthcare integrity across U.S. facilities. It targets fraud, kickback schemes, and supply chain opacity through validator governance, smart contract enforcement, and public transparency. Anchored by notarized affidavits, NFT fiscal instruments, and dashboard oversight, this protocol empowers whistleblowers, mobilizes validators, and escalates complaints to federal and state regulators. It integrates secure audit trails, DAO voting logic, and asset freeze triggers to ensure accountability, reform, and systemic trust.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016

New York, 10016, United States

About this study

The PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed to restore healthcare integrity across U.S. facilities. It targets fraud, kickback schemes, and supply chain opacity through validator governance, smart contract enforcement, and public transparency. Anchored by notarized affidavits, NFT fiscal instruments, and dashboard oversight, this protocol empowers whistleblowers, mobilizes validators, and escalates complaints to federal and state regulators. It integrates secure audit trails, DAO voting logic, and asset freeze triggers to ensure accountability, reform, and systemic trust.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Facility has documented billing, compliance, or procurement irregularities.

Facility participates in coalition validator onboarding and SHA-256 protocol enrollment.

Facility provides access to billing, procurement, and whistleblower-anchored datasets for auditing.

Exclusion criteria

Facility refuses validator onboarding or coalition integration.

Facility lacks traceable procurement or compliance records.

Facility has no whistleblower declaration or validation artifact.

Facility operates outside U.S. jurisdiction or coalition-recognized governance zones.

Treatment and study plan

Validator-Governed Reform & Regulatory Escalation Protocol

Other

This intervention deploys a validator-governed framework to monitor, escalate, and reform healthcare facilities exhibiting fraud, kickback schemes, and supply chain vulnerabilities. It integrates notarized affidavits, smart contract enforcement, NFT fiscal declarations, and DAO voting logic to trigger sanctions, regulatory complaints, and operational restructuring. Facilities are observed prospectively, with all actions logged to a public dashboard and anchored via SHA-256 hash notarization. No biospecimens are retained; all data is legal, technical, and governance-based.

Other names: PHX-AFK-US Protocol

Coalition-Grade Validator Dashboard Module (CVDM-1)

Device

The Coalition-Grade Validator Dashboard Module (CVDM-1) is a secure, web-based device deployed across enrolled healthcare facilities to enable real-time validator oversight, whistleblower affidavit intake, and smart contract enforcement. It integrates QR-linked audit trails, NFT fiscal declarations, and DAO voting logic. The device anchors all inputs via SHA-256 hash notarization and transmits reform metrics to coalition dashboards. CVDM-1 supports public transparency, regulatory escalation, and validator governance across the PHX-AFK-US Protocol. It does not collect biospecimens and operates solely within legal, technical, and governance domains.

Other names: PHX-AFK-US Governance Terminal

Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1)

Drug

The Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1) is a governance-based drug intervention targeting facilities with suspected fraud, kickback schemes, or supply chain irregularities involving pharmaceuticals. While not a therapeutic agent, CFPAT-1 functions as a regulatory scaffold that flags drug procurement, formulary manipulation, and referral-linked prescribing patterns. It integrates validator ballots, smart contract logic, and SHA-256 hash anchors to escalate complaints to CMS, DOJ, and state boards. All flagged drugs are traced via QR-linked audit trails and NFT fiscal declarations. No biospecimens are retained; the intervention operates within legal, technical, and governance domains.

Other names: CFPAT-1

Primary outcomes

  1. Change in Fraudulent Billing and Kickback Incidents Across Enrolled Facilities

    Time frame: Baseline to 12 Months Post-Validator Onboarding

    Description:

    This outcome measures the change in frequency and severity of fraudulent billing practices-including upcoding, phantom billing, and referral-based kickback schemes-across facilities enrolled in the SHA-256 Trial Protocols.

    Facilities are assessed using the Unified Impact Index derived from:

    Historical billing anomalies

    Validator audit results

    Whistleblower declarations

    SHA-256 hash-anchored incident reports

    Facilities are ranked and monitored for reform compliance, ethical standards, and onboarding validation. All scoring logic is notarized and displayed via coalition dashboards.

    Time Frame: Baseline to 12 Months Post-Validator Onboarding.

Secondary outcomes

  1. Change in Supply-Chain Traceability and Compliance Across Enrolled Facilities

    Time frame: Baseline to 12 Months Post-Validator Onboarding

    This outcome measures change in traceability and regulatory compliance for pharmaceuticals, medical devices, and non-pharmaceutical supplies. Facilities are evaluated using:

    Validator Traceability Score (VTS) composite metrics

    NFT tagging for supply-chain nodes

    Blockchain-based audit trails

    Comparative analysis dashboards identifying gaps and escalation pathways for non-compliant entities

Sponsors and collaborators

Lead sponsor

Truway Health, Inc.

Industry

Registry information

Official study title

§ PHX-AFK-US: Public Health Exchange Protocol for Anti-Fraud, Kickback Prevention & Secure Chain Integrity in U.S. Healthcare Facilities

Acronym: PHX-AFK-US

Important dates

Study start
2025
Primary completion
2034
Study completion
2034
First posted
Oct 16, 2025
Registry last updated
Oct 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.